The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2023

Filed:

Dec. 21, 2021
Applicant:

Church & Dwight Co., Inc., Princeton, NJ (US);

Inventors:

Noah Paul Zimmerman, Chapel Hill, NC (US);

Amy Wescott, Rubicon, WI (US);

Assignee:

Church & Dwight Co., Inc., Princeton, NJ (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 35/742 (2015.01); C12N 1/20 (2006.01); C12R 1/125 (2006.01);
U.S. Cl.
CPC ...
A61K 35/742 (2013.01); C12N 1/205 (2021.05); C12R 2001/125 (2021.05);
Abstract

Compositions and methods for converting at least one glucosinolate to an isothiocyanate using839,CO4_4,M3_H01, and/orM2_H12, or active variants thereof, are provided. Conversion of glucosinolates, such as glucoraphanin, to isothiocyanates, such as sulforaphane, leads to the stimulation of the Nrf2/Keap pathway and phase II enzymes, providing chemoprotective and anti-inflammatory effects. Accordingly, provided herein are compositions comprising839,CO4_4,M3_H01, and/orM2_H12, or active variants thereof, for administration to subjects for increasing isothiocyanate (e.g., sulforaphane) production, increasing the expression of genes regulated by the Nrf2 transcription factor, including phase II enzymes, decreasing inflammation, and treating or preventing an inflammatory disorder or a cancer. The composition can comprise at least one glucosinolate or a plant, plant part or an extract thereof comprising glucosinolate(s).


Find Patent Forward Citations

Loading…